Eszopiclone

This classification denotes a sedative and hypnotic with the molecular formula C17H17ClN6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UZX80K71OE, chemically known as 4-methyl-1-piperazinecarboxylic acid ester with 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5h-pyrrolo(3,4-b)pyrazin-5-one but generally known as eszopiclone, which bears US NIH Compound Identifier 5735. European Medicines Agency schedules Eszopiclone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21373. The term ESZOPICLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 2, 2003, List 49). World Health Organization schedules eszopiclone in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule eszopiclone under HS 29337900 and SITC 51561. As of Q4 2014, ESZOPICLONE remains the US FDA Preferred Term for this commodity. Eszopiclone bears US NLM identifiers UMLS ID C1436328 and NCI Concept Code C65545. SMILES: CLC1CCC(N2C(OC(=O)N3CCN(CC3)C)C3NCCNC3C2=O)NC1.